Assay News and Research

RSS
FDA grants Illumina 510(k) clearance for VeraCode Genotyping Test for Factor V and Factor II

FDA grants Illumina 510(k) clearance for VeraCode Genotyping Test for Factor V and Factor II

Immunetics receives $2.8M contract as part of NHLBI's REDS-II project

Immunetics receives $2.8M contract as part of NHLBI's REDS-II project

Abviva receives Japanese patent for Mammastatin Serum Assay

Abviva receives Japanese patent for Mammastatin Serum Assay

Launch Diagnostics to distribute MDI's Detect-Ready MRSA assay in UK, France and Republic of Ireland

Launch Diagnostics to distribute MDI's Detect-Ready MRSA assay in UK, France and Republic of Ireland

New study shows DFA testing for H1N1 influenza unreliable in ICU patients

New study shows DFA testing for H1N1 influenza unreliable in ICU patients

MorphoSys AG (DE) - AbD Serotec enters new growth area

MorphoSys AG (DE) - AbD Serotec enters new growth area

Health Canada grants Response Biomedical Class 3 Medical Device license for RAMP RSV Assay

Health Canada grants Response Biomedical Class 3 Medical Device license for RAMP RSV Assay

WaferGen Biosystems first-quarter revenues increase to $389,785

WaferGen Biosystems first-quarter revenues increase to $389,785

SQI announces poster presentations on novel diagnostic assays at 7th International Congress on Autoimmunity

SQI announces poster presentations on novel diagnostic assays at 7th International Congress on Autoimmunity

IVAX Diagnostics first-quarter net revenues decline 1.4% to $4,655,000

IVAX Diagnostics first-quarter net revenues decline 1.4% to $4,655,000

Prometheus announces novel method for early detection of HACA during infliximab treatment

Prometheus announces novel method for early detection of HACA during infliximab treatment

Research article focuses on how IECs respond to probiotic strain B. lactis HN019

Research article focuses on how IECs respond to probiotic strain B. lactis HN019

BioGenes study documents insufficient sensitivity of ELISA-based generic HCP assay

BioGenes study documents insufficient sensitivity of ELISA-based generic HCP assay

Optivia Biotechnology launches OptiDDI Suite for assessing transporter-related DDIs

Optivia Biotechnology launches OptiDDI Suite for assessing transporter-related DDIs

Prenatal screening, genetic counseling essential for preventing alpha-thalassemia: Researchers

Prenatal screening, genetic counseling essential for preventing alpha-thalassemia: Researchers

FDA grants EUA for IQuum's Liat Influenza A/2009 H1N1 Assay

FDA grants EUA for IQuum's Liat Influenza A/2009 H1N1 Assay

Harbor BioSciences reports encouraging results from Triolex Phase IIa trials

Harbor BioSciences reports encouraging results from Triolex Phase IIa trials

Evotec and Genentech sign drug discovery deal

Evotec and Genentech sign drug discovery deal

Creator of California Tay-Sachs Disease Prevention Program among the honorees

Creator of California Tay-Sachs Disease Prevention Program among the honorees

Nanosphere reports $0.8 million revenue for first-quarter 2010

Nanosphere reports $0.8 million revenue for first-quarter 2010

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.